
Isatuximab plus Iberdomide maintenance helps MRD-positive myeloma patients turn MRD-negative after transplant, with manageable safety.
In this clip, Brooke Griffin, PharmD, from Midwestern University, discusses the pharmacist's role in assessing patient eligibility for hormonal contraception.
At the American Pharmacists Association's Annual Meeting (






